A dynamic prognostic model to predict survival in primary
myelofibrosis: a study by the IWG-MRT (International
Working Group for Myeloproliferative Neoplasms Research
and Treatment)
by Francesco Passamonti, Francisco Cervantes, Alessandro Maria Vannucchi,
Enrica Morra, Elisa Rumi, Arturo Pereira, Paola Guglielmelli, Ester Pungolino,
Marianna Caramella, Margherita Maffioli, Cristiana Pascutto, Mario Lazzarino, Mario
Cazzola, and Ayalew Tefferi
Blood
Volume 115(9):1703-1708
March 4, 2010
©2010 by American Society of Hematology
Validation of the Cervantes et al score in 525 patients with primary myelofibrosis.
Francesco Passamonti et al. Blood 2010;115:1703-1708
©2010 by American Society of Hematology
Cumulative incidence of acquisition of risk factors during follow-up, estimated with death as a
competing risk in patients with primary myelofibrosis.
Francesco Passamonti et al. Blood 2010;115:1703-1708
©2010 by American Society of Hematology
Kaplan-Meier estimate of survival in primary myelofibrosis according to the DIPSS. Risk
categories were according to the score obtained anytime during follow-up.
Francesco Passamonti et al. Blood 2010;115:1703-1708
©2010 by American Society of Hematology
Kaplan-Meier estimate of survival in primary myelofibrosis according to the aaDIPSS.
Francesco Passamonti et al. Blood 2010;115:1703-1708
©2010 by American Society of Hematology